The evolution to PanIN2 needs additional mutations in tumor suppressor genes like CDKN2A. Inactivation of other suppressor genes like SMAD4, BRCA2, TP53, etc. occurs at PanIN3 or high-grade dysplasia, considered as carcinoma in situ, and in PDAC. Here, BRCA2 is linked to cancer.